Drug profile · INN
cetrorelix
CETROTIDE
cetrorelix (CETROTIDE) is a gonadotropin-releasing hormone receptor antagonist. Associated with Merck KGaA, Darmstadt, Germany.
EMA: approved TGA: approved Systemic hormonal preparations (H01) H01CC02
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — cetrorelix
- Class
- Systemic hormonal preparations (H01)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
cetrorelix (CETROTIDE) is a gonadotropin-releasing hormone receptor antagonist. Associated with Merck KGaA, Darmstadt, Germany.
Key facts
INN cetrorelix
Brand CETROTIDE
Mechanism Gonadotropin-releasing hormone receptor antagonist
Therapeutic class Systemic hormonal preparations (H01)
ATC code H01CC02
Originator Merck KGaA, Darmstadt, Germany
Mechanism of action
Gonadotropin-releasing hormone receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cetrorelix?
cetrorelix (CETROTIDE) is a gonadotropin-releasing hormone receptor antagonist. Associated with Merck KGaA, Darmstadt, Germany.
What is the brand name for cetrorelix?
CETROTIDE is a marketed brand name for cetrorelix. Check FDA Drugs@FDA for the current US label holder and prescribing information.